Swiss National Bank Has $7.57 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Swiss National Bank lowered its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 398,700 shares of the medical instruments supplier’s stock after selling 6,600 shares during the period. Swiss National Bank owned 0.20% of DENTSPLY SIRONA worth $7,567,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Sequoia Financial Advisors LLC grew its holdings in DENTSPLY SIRONA by 35.8% during the 4th quarter. Sequoia Financial Advisors LLC now owns 11,556 shares of the medical instruments supplier’s stock worth $219,000 after acquiring an additional 3,048 shares during the period. HighTower Advisors LLC grew its holdings in DENTSPLY SIRONA by 41.3% during the 4th quarter. HighTower Advisors LLC now owns 24,480 shares of the medical instruments supplier’s stock worth $465,000 after acquiring an additional 7,152 shares during the period. AGF Management Ltd. acquired a new stake in DENTSPLY SIRONA during the 4th quarter worth $2,535,000. Cooke & Bieler LP grew its holdings in DENTSPLY SIRONA by 24.3% during the 4th quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier’s stock worth $174,101,000 after acquiring an additional 1,794,391 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in DENTSPLY SIRONA by 35.2% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 58,213 shares of the medical instruments supplier’s stock worth $1,105,000 after acquiring an additional 15,162 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

Insider Transactions at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 15,142 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The shares were acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.52% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms have commented on XRAY. Barrington Research lowered their target price on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a report on Friday, February 28th. Robert W. Baird decreased their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a report on Friday, February 28th. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Wells Fargo & Company decreased their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a report on Friday, February 28th. Finally, Jefferies Financial Group cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and cut their price objective for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Twelve equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $23.33.

DENTSPLY SIRONA Trading Down 0.3 %

Shares of NASDAQ:XRAY opened at $15.56 on Friday. The stock has a market capitalization of $3.10 billion, a PE ratio of -7.52, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. The company’s 50-day moving average price is $17.92 and its two-hundred day moving average price is $20.50. DENTSPLY SIRONA Inc. has a one year low of $14.78 and a one year high of $33.42. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.16 per share. The ex-dividend date is Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 4.11%. DENTSPLY SIRONA’s dividend payout ratio is presently -14.07%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.